According to Endo International 's latest financial reports the company's total debt is $5.08 M. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $5.08 M | -15.65% |
2022-12-31 | $6.03 M | -99.93% |
2021-12-31 | $8.29 B | -0.84% |
2020-12-31 | $8.36 B | -1.05% |
2019-12-31 | $8.45 B | 2.36% |
2018-12-31 | $8.25 B | -0.22% |
2017-12-31 | $8.27 B | 0.05% |
2016-12-31 | $8.27 B | -3.59% |
2015-12-31 | $8.58 B | 101.58% |
2014-12-31 | $4.25 B | 13.85% |
2013-12-31 | $3.73 B | 18.05% |
2012-12-31 | $3.16 B | -9.83% |
2011-12-31 | $3.51 B | 228.04% |
2010-12-31 | $1.07 B | 231.99% |
2009-12-31 | $0.32 B | 32.65% |
2008-12-31 | $0.24 B | |
2001-12-31 | $91.25 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Zogenix ZGNX | N/A | N/A | ๐บ๐ธ USA |
Cara Therapeutics
CARA | $6.08 M | 19.65% | ๐บ๐ธ USA |